DelaPlex IPO vs Docmode Health Technologies IPO

Comparison between DelaPlex IPO and Docmode Health Technologies IPO.

IPO Details

DelaPlex IPO is a SME Fixed Price IPO proposed to list at NSE SME while Docmode Health Technologies IPO is a SME Fixed Price proposed to list at NSE SME.

Issue Size and Price

The total issue size of DelaPlex IPO is up to ₹43.73 Cr whereas the issue size of the Docmode Health Technologies IPO is up to ₹6.37 Cr. The final issue price of DelaPlex IPO is ₹192.00 per share and of Docmode Health Technologies IPO is ₹79.00 per share.

 DelaPlex IPODocmode Health Technologies IPO
Face Value₹10 per share₹10 per share
Issue Price (Lower)₹186.00 per share
Issue Price (Upper)₹192.00 per share
Issue Price (Final)₹192.00 per share₹79.00 per share
Discount (Retail)₹0.00 per share₹0.00 per share
Discount (Employee)
Market Lot Size600 shares1600 shares
Fresh Issue Size16,77,600 shares8,06,400 shares
Fresh Issue Size (Amount)up to ₹32.21 Crup to ₹6.37 Cr
OFS Issue Size6,00,000 shares0 shares
OFS Issue Size (Amount)up to ₹11.52 Crup to ₹0.00 Cr
Issue Size Total22,77,600 shares8,06,400 shares
Issue Size Total (Amount)up to ₹43.73 Crup to ₹6.37 Cr

IPO Timetable

DelaPlex IPO opens on Jan 25, 2024, while Docmode Health Technologies IPO opens on Jan 25, 2024. The closing date of DelaPlex IPO and Docmode Health Technologies IPO is Jan 30, 2024, and Jan 30, 2024, respectively.

 DelaPlex IPODocmode Health Technologies IPO
Anchor Bid DateJan 24, 2024
Issue OpenJan 25, 2024Jan 25, 2024
Issue CloseJan 30, 2024Jan 30, 2024
Basis Of Allotment (Tentative)Jan 31, 2024Jan 31, 2024
Initiation of Refunds (Tentative)Jan 31, 2024Feb 01, 2024
Credit of Share (Tentative)Feb 01, 2024Feb 01, 2024
Listing date (Tentative)Feb 02, 2024Feb 02, 2024
Anchor Lockin End date 1Mar 01, 2024
Anchor Lockin End date 2Apr 30, 2024

Financials & KPIs

DelaPlex IPO P/E ratio is 17.75, as compared to Docmode Health Technologies IPO P/E ratio of 9.3.

 DelaPlex IPODocmode Health Technologies IPO
Financials

Company Financials (Restated)

Period Ended30 Sep 202331 Mar 202331 Mar 202231 Mar 2021
Assets31.8526.3817.9111.01
Total Income28.1455.2250.3436.33
Profit After Tax4.267.916.124.04
NET Worth27.7623.5015.599.47
Reserves and Surplus27.7523.4915.589.46
Amount in ₹ Crore

Company Financials (Restated Consolidated)

Period Ended30 Sep 202331 Mar 202331 Mar 202231 Mar 2021
Assets17.6417.0110.085.67
Total Income23.6732.9712.447.10
Profit After Tax1.361.950.920.55
NET Worth4.843.481.390.47
Reserves and Surplus2.541.181.380.46
Total Borrowing8.118.484.841.06
Amount in ₹ Crore
Promoter Shareholding (Pre-Issue)10065.02
Promoter Shareholding (Post-Issue)73.6647.44
P/E Ratio17.759.3
Market Cap₹174.91 Cr.₹24.83 Cr.
ROE40.45%80.03%
ROCE56.73%22.46%
Debt/Equity2.44
EPS₹10.82₹8.50
RoNW56.73%56.06%

Shares Offered

In the DelaPlex IPO Retail Individual Investors (RII) are offered 7,97,400 shares while in Docmode Health Technologies IPO retail investors are offered 7,97,400 shares. Qualified Institutional Buyers (QIB) are offered 4,55,400 shares in DelaPlex IPO and in Docmode Health Technologies IPO.

 DelaPlex IPODocmode Health Technologies IPO
Anchor Investor Reservation6,82,800 shares
Market Maker Reservation1,22,400 shares43,200 shares
QIB4,55,400 shares
NII3,42,000 shares4,03,200 shares
RII7,97,400 shares4,03,200 shares
Employee
Others
Total22,77,600 shares8,06,400 shares

Bids Received (Subscription)

DelaPlex IPO subscribed 177.80x in total, whereas Docmode Health Technologies IPO subscribed 215.24x.

Compare with others

Compare: